Cadrenal Therapeutics Inc (CVKD) Stock Price

13.86 ▼ -1.13 (-7.54%)
Open: 14.69 Vol: 19.71K Day's range: 13.6663 - 14.69 Jun 13, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
CVKD Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 14.20▼ 14.27▼ 14.27▼ 14.73▼ 14.51▼
MA10 14.46▼ 14.55▼ 14.61▼ 14.61▼ 15.20▼
MA20 14.74▼ 14.77▼ 14.78▼ 14.66▼ 16.92▼
MA50 14.80▼ 14.92▼ 14.79▼ 15.35▼ 14.17▼
MA100 14.85▼ 14.93▼ 15.25▼ 17.06▼ 12.01▲
MA200 15.13▼ 15.78▼ 16.32▼ 15.36▼ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD -0.110▼ -0.124▼ -0.133▼ 0.082▲ -0.590▼
RSI 26.048▼ 30.297▼ 33.389▼ 41.840▼ 44.463▼
STOCH 2.263▼ 1.177▼ 1.522▼ 58.208     21.641    
WILL %R -100.000▼ -100.000▼ -100.000▼ -77.737▼ -89.575▼
CCI -193.355▼ -186.305▼ -183.455▼ -37.484     -79.371    
Latest Filters Detected On CVKD
RSI $CVKD RSI(14) Crossed Below 50 Set Alert
▼ MA $CVKD MA(50) Crossed Below MA(200) Set Alert
MA $CVKD Price Crossed Below MA(26) Set Alert
MA $CVKD Price Crossed Below MA(13) Set Alert
▼ GAP $CVKD Open Gap Down %2 Set Alert
Cadrenal Therapeutics Inc News
Cadrenal Therapeutics Stock Short Interest Report | NASDAQ:CVKD | Benzinga
Sunday, May 18, 2025 12:49 PM
Short interest in Cadrenal Therapeutics Inc (NASDAQ:CVKD) decreased during the last reporting period, falling from 32.09K to 23.35K. This put 1.62% of the company's publicly available shares short.
$34 Billion Market in 2025 Advancing to $45 Billion in 2026 for Phase III Development of New Blood Thiner, Less Problematic Than Warfrain: Cadrenal Therapeutics, Inc. (Nasdaq ...
Tuesday, May 13, 2025 02:32 PM
Collaboration Agreement with Abbott: In March CVKD announced a Collaboration Agreement with Abbott (NYSE: ABT) to support its pivotal TECarfarin Anticoagulation and Hemocompatibility with Left ...
CVKD: Preparations Continue for Phase 3 Trial of Tecarfarin…
Wednesday, May 07, 2025 05:00 PM
Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) is a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant intended to prevent heart attacks, stroke ...
CVKD historical stock data
date open high low close volume
13/06/25 14.69 14.69 13.6663 13.86 19,714
12/06/25 15.31 15.99 14.5112 14.99 38,419
11/06/25 14.91 15.00 14.625 15.00 12,715
10/06/25 14.89 14.955 14.80 14.80 19,780
09/06/25 15.50 15.50 14.87 15.00 23,245
06/06/25 15.40 15.50 14.90 15.10 23,719
05/06/25 15.68 15.68 14.493 14.61 20,400
04/06/25 13.70 15.8678 13.70 15.49 66,078
03/06/25 13.55 13.69 13.2535 13.69 17,933
02/06/25 13.26 13.7637 13.25 13.54 19,357
Quote Details
52wk Low:5.70
52wk High:22.901
Vol:19.71K
Avg Vol(3m):378.9K
1Y Chng:+98.88%
1M Chng:-15.74%
Add to Watch List
More Information
Index US Composite
Market Cap. 29.48M